Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An update from AOTI, Inc. ( (GB:AOTI) ) is now available.
AOTI, Inc. reported significant progress in its market access and commercial expansion strategy, highlighted by its penetration into higher value segments such as Medicaid, Workers’ Compensation, and Long-Term Acute Care. The company is expanding its revenue streams beyond the Veterans Administration market with new provider registrations in nine Medicaid states, contributing to a monthly run rate exceeding $2 million. Their Topical Wound Oxygen (TWO2) therapy is gaining increased recognition for its health benefits, which is further driving market adoption and supporting AOTI’s strategic growth initiatives. The company’s expanded sales team and strategic focus position it well for continued momentum in the Advanced Wound Care market, with expectations of strong growth in the coming years.
More about AOTI, Inc.
AOTI, Inc. is a medical technology company founded in 2006, based in Oceanside, California, US, and Galway, Ireland. The company focuses on innovative solutions for severe and chronic wounds, aiming to reduce healthcare costs and improve patient quality of life. Their patented Topical Wound Oxygen (TWO2) therapy has shown significant success in reducing the recurrence of Diabetic Foot Ulcers (DFUs), hospitalizations, and amputations. It has received regulatory clearance from authorities in several regions, including the US (FDA) and Europe (CE Mark).
YTD Price Performance: -2.70%
Average Trading Volume: 20,788
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £118.1M
Learn more about AOTI stock on TipRanks’ Stock Analysis page.
